Docetaxel (taxotere®) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer
- 1 December 1998
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 34 (13), 2032-2036
- https://doi.org/10.1016/s0959-8049(98)00287-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Combination therapy with gemcitabine in non-small cell lung cancerEuropean Journal Of Cancer, 1997
- Promising new agents in the treatment of non-small cell lung cancerCancer Chemotherapy and Pharmacology, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Docetaxel (Taxotere®) a review of preclinical and clinical experience. Part IAnti-Cancer Drugs, 1995
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- The World Health Organization Histological Typing of Lung Tumours: Second EditionAmerican Journal of Clinical Pathology, 1982